3 Year Absolute Returns
89.25% ↑
NAV (₹) on 27 Mar 2026
33.41
1 Day NAV Change
-1.02%
Risk Level
Very High Risk
Rating
-
Tata India Pharma & HealthCare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by Tata Asset Management Ltd.. Launched on 04 Dec 2015, investors can start with a minimum ... Read more
AUM
₹ 1,300.81 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 58.69% |
| Hospitals & Medical Services | 35.52% |
| Agro Chemicals/Pesticides | 3.33% |
| Cash | 2.24% |
| CBLO/Reverse Repo | 0.20% |
| Medical Equipment & Accessories | 0.02% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. | 9.66% | ₹ 125.61 | Pharmaceuticals |
| MAX HEALTHCARE INSTITUTE LTD. | 6.78% | ₹ 88.23 | Hospitals & Medical Services |
| DIVI LABORATORIES LTD. | 5.94% | ₹ 77.29 | Pharmaceuticals |
| ABBOTT INDIA LTD. | 5.60% | ₹ 72.83 | Pharmaceuticals |
| HEALTHCARE GLOBAL ENTERPRISES LTD. | 5.04% | ₹ 65.61 | Hospitals & Medical Services |
| APOLLO HOSPITALS ENTERPRISE LTD. | 5.00% | ₹ 65.04 | Hospitals & Medical Services |
| CIPLA LTD. | 4.55% | ₹ 59.16 | Pharmaceuticals |
| RAINBOW CHILDRENS MEDICARE LTD. | 3.83% | ₹ 49.84 | Hospitals & Medical Services |
| MANKIND PHARMA LTD | 3.40% | ₹ 44.27 | Pharmaceuticals |
| BAYER CROPSCIENCE LTD. | 3.33% | ₹ 43.37 | Agro Chemicals/Pesticides |
| FORTIS HEALTHCARE LTD. | 3.27% | ₹ 42.56 | Hospitals & Medical Services |
| SAI LIFE SCIENCES LTD | 3.25% | ₹ 42.33 | Pharmaceuticals |
| J.B.CHEMICALS & PHARMACEUTICALS LTD. | 3.21% | ₹ 41.71 | Pharmaceuticals |
| METROPOLIS HEALTHCARE LTD. | 3.13% | ₹ 40.68 | Hospitals & Medical Services |
| LUPIN LTD. | 3.08% | ₹ 40.11 | Pharmaceuticals |
| DR REDDYS LABORATORIES LTD. | 3.04% | ₹ 39.60 | Pharmaceuticals |
| DR. LAL PATH LABS LTD. | 2.71% | ₹ 35.28 | Hospitals & Medical Services |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD. | 2.64% | ₹ 34.36 | Hospitals & Medical Services |
| SYNGENE INTERNATIONAL LTD. | 2.39% | ₹ 31.15 | Pharmaceuticals |
| CASH / NET CURRENT ASSET | 2.24% | ₹ 28.68 | Others |
| ALKEM LABORATORIES LTD. | 2.15% | ₹ 28.01 | Pharmaceuticals |
| AJANTA PHARMA LTD. | 2.06% | ₹ 26.77 | Pharmaceuticals |
| NEULAND LABORATORIES LTD. | 2.00% | ₹ 25.99 | Pharmaceuticals |
| SANOFI INDIA LTD. | 1.99% | ₹ 25.88 | Pharmaceuticals |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD. | 1.82% | ₹ 23.72 | Pharmaceuticals |
| FDC LTD. | 1.82% | ₹ 23.64 | Pharmaceuticals |
| VIJAYA DIAGNOSTIC CENTRE LTD. | 1.55% | ₹ 20.17 | Hospitals & Medical Services |
| GLOBAL HEALTH LTD. | 1.50% | ₹ 19.57 | Hospitals & Medical Services |
| TORRENT PHARMACEUTICALS LTD. | 1.07% | ₹ 13.90 | Pharmaceuticals |
| CORONA REMEDIES LTD | 0.99% | ₹ 12.93 | Pharmaceuticals |
| HIKAL LTD. | 0.60% | ₹ 7.75 | Pharmaceuticals |
| REPO | 0.20% | ₹ 2.61 | Others |
| JUBILANT PHARMOVA LTD | 0.07% | ₹ 0.93 | Pharmaceuticals |
| DR. AGARWALS HEALTH CARE LTD. | 0.07% | ₹ 0.91 | Hospitals & Medical Services |
| LAXMI DENTAL LIMITED | 0.02% | ₹ 0.28 | Medical Equipment & Accessories |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | -3.87% | 1.24% | 8.72% | 23.69% |
| Category returns | -6.96% | 1.07% | 6.24% | 23.23% |
The investment objective of the scheme is to seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & ... Read more
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Canara Robeco Consumer Trends Fund - Direct Plan
Diversified
Direct
|
₹75.07 | -9.30% | 32.38% | 54.69% | ₹1,950 | 0.82% |
Very High
|
|
Canara Robeco Consumer Trends Fund - Direct Plan
Diversified
Direct
|
₹75.07 | -9.30% | 32.38% | 54.69% | ₹1,950 | 0.82% |
Very High
|
|
Quantum ESG Best In Class Strategy Fund
Diversified
Regular
|
₹20.89 | -6.99% | 32.30% | 47.42% | ₹95 | 2.18% |
Very High
|
|
DSP Quant Fund
Largecap
Regular
|
₹19.83 | -1.18% | 32.19% | 43.66% | ₹838 | 1.25% |
Very High
|
|
SBI Technology Opportunities Fund
Sector
Regular
|
₹108.99 | -9.58% | 32.11% | 72.26% | ₹4,273 | 1.92% |
Very High
|
|
SBI Technology Opportunities Fund
Sector
Regular
|
₹108.99 | -9.58% | 32.11% | 72.26% | ₹4,273 | 1.92% |
Very High
|
|
SBI Technology Opportunities Fund
Sector
Regular
|
₹180.99 | -9.58% | 32.10% | 72.24% | ₹4,273 | 1.92% |
Very High
|
|
Axis Innovation Fund - Direct Plan
Diversified
Direct
|
₹15.31 | -5.26% | 32.10% | 49.80% | ₹1,121 | 1.31% |
Very High
|
|
Axis Innovation Fund - Direct Plan
Sector
Direct
|
₹15.31 | -5.26% | 32.10% | 49.80% | ₹1,121 | 1.31% |
Very High
|
|
Tata Ethical Fund - Direct Plan
Sector
Direct
|
₹215.33 | -5.17% | 31.65% | 66.52% | ₹3,715 | 0.71% |
Very High
|
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Tata Equity Savings Fund - Regular Plan
Hybrid
Regular
|
₹27 | 6.88% | 32.55% | 46.95% | ₹285 | 1.15% |
Low to Moderate
|
|
Tata Equity Savings Fund - Regular Plan
Hybrid
Regular
|
₹27 | 6.88% | 32.55% | 46.95% | ₹285 | 1.15% |
Low to Moderate
|
|
Tata Equity Savings Fund - Regular Plan - Growth
Hybrid
Regular
|
₹56.36 | 6.88% | 32.55% | 47.04% | ₹285 | 1.15% |
Low to Moderate
|
|
Tata Childrens Fund - Direct Plan
Diversified
Direct
|
₹58.24 | -7.83% | 32.11% | 61.34% | ₹344 | 1.99% |
Very High
|
|
Tata Ethical Fund - Direct Plan
Sector
Direct
|
₹215.33 | -5.17% | 31.65% | 66.52% | ₹3,715 | 0.71% |
Very High
|
|
Tata Ethical Fund - Direct Plan
Sector
Direct
|
₹215.33 | -5.17% | 31.65% | 66.52% | ₹3,715 | 0.71% |
Very High
|
|
Tata Ethical Fund - Direct Plan
Sector
Direct
|
₹392.25 | -5.16% | 31.65% | 66.56% | ₹3,715 | 0.71% |
Very High
|
|
Tata BSE Sensex Index Fund - Direct Plan
Index
Direct
|
₹195.89 | -4.46% | 30.89% | 55.77% | ₹399 | 0.29% |
Very High
|
|
Tata Large & Mid Cap Fund - Regular Plan
Diversified
Regular
|
₹71.62 | -9.88% | 30.71% | 61.20% | ₹8,143 | 1.78% |
Very High
|
|
Tata Large & Mid Cap Fund - Regular Plan
Diversified
Regular
|
₹71.62 | -9.88% | 30.71% | 61.20% | ₹8,143 | 1.78% |
Very High
|
What is the current NAV of Tata India Pharma & HealthCare Fund - Direct Plan IDCW-Payout?
What is the fund size (AUM) of Tata India Pharma & HealthCare Fund - Direct Plan IDCW-Payout?
What are the historical returns of Tata India Pharma & HealthCare Fund - Direct Plan IDCW-Payout?
What is the risk level of Tata India Pharma & HealthCare Fund - Direct Plan IDCW-Payout?
What is the minimum investment amount for Tata India Pharma & HealthCare Fund - Direct Plan IDCW-Payout?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article